Trial Profile
Contrast kinetics of Gadobutrol in dynamic contrast-enhanced MRI of the breast in patients with histologically proven breast cancers initially classified as BIRADS 5 with and without a computer aided detection system.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 03 Mar 2015 New trial record